<DOC>
	<DOC>NCT01265446</DOC>
	<brief_summary>This study will compare the efficacy and safety of a single dose of a lidocaine 8 mg + cetylpyridimium chloride (CPC) 2 mg lozenge with a single dose of a lidocaine 1 mg + CPC 2 mg lozenge in the treatment of sore throat due to a common cold.</brief_summary>
	<brief_title>Efficacy and Safety of a Sore Throat Lozenge Containing Lidocaine and Cetylpyridinium Chloride in Patients With Sore Throat Due to a Common Cold.</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Cetylpyridinium</mesh_term>
	<criteria>Patients with sore throat due to an upper respiratory tract infection, with recent onset (within 48 hours) Sore throat of at least moderate pain intensity History of hypersensitivity to any of the study drugs and listed excipients or to drugs of similar chemical classes Evidence of mouth breathing or severe coughing Evidence of overt oropharyngeal bacterial or fungal infection or evidence of lower respirator tract infection Severe renal, liver or cardiac impairment Severe lung disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Sore throat, upper respiratory tract infection, lozenge with lidocaine and cetylpyridinium chloride.</keyword>
</DOC>